Quest Diagnostics
NYSE: DGX
$122.25
-$0.46 (-0.4%)
Closing price July 15, 2020
One of the most important aspects of reopening the economy during this pandemic is testing for COVID-19. Credit Suisse sees a couple of winners benefitting incredibly from this.
2 days ago
These are four top telehealth plays for growth investors that offer a way to not only catch the swelling trend but to have a health care position for portfolios that should remain strong for the rest...
15 days ago
Tuesday's top analyst upgrades and downgrades included Avaya, Biogen, Broadcom, Chevron, Domino's Pizza, eBay, MGIC Investment, RealReal, Sprout Social, T-Mobile, Zoom Video Communications and Zynga.
1 month ago
Last Updated: 1 month ago
Investors look at Aytu BioScience as it looks at expanding in the COVID testing field.
1 month ago
Last Updated: 1 month ago
Aytu BioScience has a distribution agreement for a COVID-19 rapid test and is developing a potential UV light-based treatment.
1 month ago
Last Updated: 1 month ago
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.
2 months ago
Tuesday's top analyst upgrades and downgrades included AT&T, Cognex, Johnson & Johnson, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero Energy and Walt Disney.
2 months ago
Last Updated: 2 months ago
Monday's top analyst upgrades and downgrades included Amazon.com, American Airlines, American Express, Beyond Meat, Caterpillar, Clorox, eBay, Gilead Sciences, Twitter, Verizon Communications and...
2 months ago
Last Updated: 2 months ago
Aytu BioScience has been one of the biggest winners in the fight against the novel coronavirus. The company is sending 2,700 COVID-19 rapid tests to Denver for use with first responders.
2 months ago
Co-Diagnostics has been the toast of Wall Street after it went from penny stock status to a revered coronavirus testing stock.
3 months ago
Investors have begun trying to position themselves for the rest of 2020 in a post-bull market climate. One haven for investors throughout good times and hard times has been companies with safe and...
3 months ago
GenMark Diagnostics shares shot up early on Wednesday after the company provided an update on its quarterly numbers and where it stands with its coronavirus test.
3 months ago
Co-Diagnostics shares popped on Monday after the company announced a key update from the FDA on its COVID-19 test kit.
3 months ago
Becton, Dickinson is officially throwing its hat in the ring to fight COVID-19. Specifically, this firm is working on the front end by testing for the disease and antibodies that have been built up...
3 months ago
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
3 months ago